home about us journals search

African Journal of Biotechnology

     
   AJB Home
   About AJB
   Submit Manuscripts
   Instructions for Authors
   Editors
   Call For Paper
   Archive
   Faculty 1000
   Conferences
   Associations

  Afr. J. Biotechnol.

  Vol. 9 No. 8

  Viewing options:

    • Abstract
    •Reprint (PDF) (91K)

  Search Pubmed for articles by:

  Pehlivan S
  Pehlivan M

 


  Other links:
  PubMed Citation
  Related articles in PubMed

Related Journals
African Journal of Agricultural Research
African Journal  of Environmental Science & Technology
Biotechnology & Molecular Biology Reviews

African Journal of Biochemistry Research

African Journal of Microbiology Research
African Journal of Pure & Applied Chemistry
African Journal of Food Science
Journal of Cell & Animal Biology
African Journal of Pharmacy & Pharmacology

African Journal of Plant Science
Journal of Medicinal Plant Research
International Journal of Physical Sciences
Scientific Research and Essays
 

African Journal of Biotechnology Vol. 9 (8), pp. 1255-1258, 22 February 2010

ISSN 1684-5315  © 2010 Academic Journals  

 

 

Full Length Research Paper

 

Thalassemia mutations in Gaziantep, Turkey

 

Sacide Pehlivan1*, Vahap Okan2, Elif Guler3, Mehmet Yilmaz2, Tugce Sever1, Ebru Dikensoy4, Gaye Cankus 1, Ozcan Balat4 and Mustafa Pehlivan2

 

1Department of Medical Biology and Genetic, Gaziantep University School of Medicine, Gaziantep, TR-27310, Turkey.

2Department of Hematology, Gaziantep University School of Medicine, Gaziantep, TR-27310, Turkey.

3Department of Pediatric Oncology, Gaziantep University School of Medicine, Gaziantep, TR-27310, Turkey.

4Department of Obstetrics and Gynecology, Gaziantep University School of Medicine, Gaziantep, TR-27310, Turkey.

 

*Corresponding author. E-mail: psacide@hotmail.com or spehlivan@gantep.edu.tr. Tel: +90 533 6391813. Fax: +90 342 3606028. Office: +90 342 360 6060. Internal: 77774.

 

Accepted 19 January, 2010

 

   Abstract

 

Ninety-eight postnatal and six prenatal cases of thalassemia were studied by the reverse dot-blot hybridization technique in the city of Gaziantep, Turkey. We found the following mutations: IVS 1.110 (G>A) in 29.1%, IVS 2.1 (G>A) in 12.3%, IVS 1.1 (G>A) in 7.7%, Codon 8 (−AA) in 5.6%, -30 (T>A) in 4.6%, IVS 1.6 (T>C) in 4.6%, Codon 39 (C>T) in 3.6%, Codon 44 (-C) in 3.1%, IVS 2.745 (C>G) in 1.5%, Codon 8/9 (+G) in 2.1%, Codon 36/37 (-T) in 2.1%, IVS 1.5 (G>C) in 2.1%, Codon 22 (7pb del) in 0.5%, Codon 5 (-CT) in 0.5% while 20.9% were undetermined. 54 of the thalassemia patients were homozygotes, 12 were compound heterozygous and 31 were heterozygotes. In one allele of 5 thalassemia patients, α-thalassemia mutation (3.7 single gene deletions in 1 patient, anti-3.7 gene triplication in 4 patients) was determined at the same time. Finally, this is the first comprehensive study in this region and percentage of α and β- globin genes mutation is 2.6 and 79.4%, respectively.

 

Key words: α- thalassemia, β -thalassemia, DNA, mutation, polymerase chain reaction.

___________________________________________________________________________________________________________

Advertise on AJB | Terms of Use | Privacy Policy | Help

© Academic Journals 2002 - 2010